Remora Capital
Jul 22, 20194 min read
Telix Pharmaceuticals Reports Positive Consultation for European Approval of Prostate Imaging Agent
Program relevance: TLX591-CDx (68Ga-PSMA-11) for the imaging of metastatic prostate cancer with positron emission tomography (PET)...

